MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ELVN has $476,168K in assets. $16,568K in debts. $98,896K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2866.24%
Quick Ratio
2866.24%
Cash Ratio
596.91%
Debt to Asset Ratio
3.48%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
98,896
Marketable securities
363,725
Restricted cash
0
Prepaid expenses and other current assets
12,257
Total current assets
474,878
Property and equipment, net
34
Operating lease right-of-use assets
383
Deferred offering costs
217
Other long-term assets
656
Total assets
476,168
Accounts payable
2,159
Accrued expenses and other current liabilities
14,409
Total current liabilities
16,568
Total liabilities
16,568
Common stock, par value 0.001 authorized shares - 100,000,000 issued and outstanding shares - 59,440,045 and 48,936,459 at december 31, 2025 and 2024, respectively
59
Additional paid-in capital
806,373
Accumulated other comprehensive income
334
Accumulated deficit
-347,166
Total stockholders' equity
459,600
Total liabilities and stockholders' equity
476,168
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$363,725K Cash and cashequivalents$98,896K Prepaid expenses andother current assets$12,257K Total current assets$474,878K Other long-termassets$656K Operating leaseright-of-use assets$383K Deferred offering costs$217K Property and equipment,net$34K Total assets$476,168K Total liabilities andstockholders' equity$476,168K Total stockholders'equity$459,600K Total liabilities$16,568K Accumulated deficit-$347,166K Additional paid-in capital$806,373K Total currentliabilities$16,568K Accumulated othercomprehensive income$334K Common stock, par value0.001 authorized...$59K Accrued expenses andother current...$14,409K Accounts payable$2,159K

Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics, Inc. (ELVN)